SURE

Article

Chenevas-Paule, Clemence, Wolff, Hans, Ashton, Mark, Schubert, Martin and Dodou, Kalliopi (2017) Development of a Predictive Model for the Stabilizer Concentration Estimation in Microreservoir Transdermal Drug Delivery Systems Using Lipophilic Pressure-Sensitive Adhesives as Matrix/Carrier. Journal of Pharmaceutical Sciences, 106 (5). pp. 1371-1383. ISSN 00223549

Chenevas-Paule, Clemence, Wolff, Hans, Ashton, Mark, Schubert, Martin and Dodou, Kalliopi (2017) Development of a predictive model for the long term stability assessment of drug-in-adhesive transdermal films using polar pressure sensitive adhesives as carrier/matrix. Journal of Pharmaceutical Sciences, 106 (5). pp. 1293-1301. ISSN 0022-3549

Wong, Rachel, Ashton, Mark and Dodou, Kalliopi (2016) Analysis of residual crosslinking agent content in UV cross-linked poly(ethylene oxide) hydrogels for dermatological application, by gas chromatography. Journal of Pharmaceutical Analysis, 6 (5). pp. 307-302. ISSN 2095-1779

Wong, Rachel, Ashton, Mark and Dodou, Kalliopi (2015) Effect of Crosslinking Agent Concentration on the Properties of Unmedicated Hydrogels. Pharmaceutics, 7 (3). pp. 305-319. ISSN 1999-4923

Ashton, Mark and Medhi, Manjul (2011) Current pharmacological treatments and research and development in HIV. The Pharmaceutical Journal, 286. pp. 695-696. ISSN 0031-6873

Ashton, Mark and Crockatt, Kay (2011) Current therapies and research and development in the treatment of asthma. The Pharmaceutical Journal, 286. pp. 569-570. ISSN 0031-6873

Sherwood, John, Ashton, Mark, Newton, Clare and Biles, Sumita (2011) Current and future options for the management of heart failure. The Pharmaceutical Journal, 286. pp. 437-438. ISSN 0031-6873

Ashton, Mark and Todd, Adam (2011) Current research and development of new treatments for schizophrenia. The Pharmaceutical Journal, 286. pp. 174-175. ISSN 0031-6873

Marth, Gabriella, Anderson, Rosaleen, Thompson, Barry G, Ashton, Mark and Groundwater, Paul (2010) Chemo- and regioselectivity in the reactions of polyfunctional pyrroles. Tetrahedron, 66 (32). pp. 6113-6120. ISSN 0040-4020

Todd, Adam, Moore, Adrian, Ashton, Mark and Van, Son (2010) Current research and development of treatments for Alzheimer’s disease. The Pharmaceutical Journal, 284 (7599). pp. 429-430. ISSN 0031-6873

Book Section

Hann, Victoria, Dawson, Peter and Ashton, Mark (2016) Allosteric Integrase Inhibitors. In: Frontiers in Clinical Drug Research-HIV. Bentham Science Publishers, UAE, pp. 49-126. ISBN 9781681082301

Hann, Victoria and Ashton, Mark (2015) HIV Integrase - Biology and Inhibitor Design. In: Frontiers in Clinical Drug Research - HIV. Bentham Science Publishers, pp. 185-286. ISBN 978-1-60805-897-6

Conference or Workshop Item

Amer, Amer H., Anderson, Rosaleen, Carlile, Mark, Dawson, Peter and Ashton, Mark (2017) A 3D-QSAR Pharmacophore based virtual screening and docking approach to identify novel HIV-1 entry inhibitors. In: New Approaches in Medicinal Chemistry II, 01 Feb 2017, Eli Lilly, Windlesham, UK. (Unpublished)

McGarry, Kenneth, Emery, Kirsty, Varnakulasingam, Vithusa, McDonald, Sharon and Ashton, Mark (2016) Complex network based computational techniques for edgetic modelling of mutations implicated with human diseases. In: 16th UK Workshop on Computational Intelligence, UKCI-2016, 7-9 Sep 2016, Lancaster University.

Wong, Rachel, Ashton, Mark, Wolff, Hans and Dodou, Kalliopi (2015) Effect of Photoinitiator Concentration on the Properties of Unmedicated Hydrogels. In: 42nd Annual Meeting & Exposition of the Controlled Release Society, 26-29 Jul 2015, Edinburgh, Scotland. (Submitted)

Chenevas-Paule, Clemence, Ashton, Mark, Wolff, Hans Michael and Dodou, Kalliopi (2014) Studies on the interaction of poly(vinylpyrrolidone) with ibuprofen, salicylic acid and aspirin. In: APS PharmSci2014: The Science of Medicines, 8-10 Sep 2014, University of Hertfordshire, Hatfied. (Unpublished)

Patents

WO2011039528 (2011) 2-PYRIDONE COMPOUNDS USED AS INHIBITORS OF NEUTROPHIL ELASTASE. WO2011039528.